vs

Side-by-side financial comparison of Dexcom (DXCM) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.

OPEN TEXT CORP is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs 12.7%, a 8.6% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -0.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -4.3%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Open Text Corporation is a global software company that develops and sells information management software.

DXCM vs OTEX — Head-to-Head

Bigger by revenue
OTEX
OTEX
1.1× larger
OTEX
$1.3B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+22.2% gap
DXCM
21.6%
-0.6%
OTEX
Higher net margin
DXCM
DXCM
8.6% more per $
DXCM
21.2%
12.7%
OTEX
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-4.3%
OTEX

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
DXCM
DXCM
OTEX
OTEX
Revenue
$1.3B
$1.3B
Net Profit
$267.3M
$168.1M
Gross Margin
62.9%
74.0%
Operating Margin
25.6%
22.0%
Net Margin
21.2%
12.7%
Revenue YoY
21.6%
-0.6%
Net Profit YoY
153.6%
-26.9%
EPS (diluted)
$0.67
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
OTEX
OTEX
Q1 26
$1.3B
Q4 25
$1.3B
$1.3B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.0B
$1.3B
Q4 24
$1.1B
$1.3B
Q3 24
$994.2M
$1.3B
Q2 24
$1.0B
$1.4B
Net Profit
DXCM
DXCM
OTEX
OTEX
Q1 26
$267.3M
Q4 25
$267.3M
$168.1M
Q3 25
$283.8M
$146.6M
Q2 25
$179.8M
$28.8M
Q1 25
$105.4M
$92.8M
Q4 24
$151.7M
$229.9M
Q3 24
$134.6M
$84.4M
Q2 24
$143.5M
$248.2M
Gross Margin
DXCM
DXCM
OTEX
OTEX
Q1 26
62.9%
Q4 25
62.9%
74.0%
Q3 25
60.5%
72.8%
Q2 25
59.5%
72.3%
Q1 25
56.9%
71.6%
Q4 24
58.9%
73.3%
Q3 24
59.7%
71.7%
Q2 24
62.4%
72.5%
Operating Margin
DXCM
DXCM
OTEX
OTEX
Q1 26
25.6%
Q4 25
25.6%
22.0%
Q3 25
20.1%
21.0%
Q2 25
18.4%
13.9%
Q1 25
12.9%
16.7%
Q4 24
17.0%
22.2%
Q3 24
15.3%
16.3%
Q2 24
15.7%
14.2%
Net Margin
DXCM
DXCM
OTEX
OTEX
Q1 26
21.2%
Q4 25
21.2%
12.7%
Q3 25
23.5%
11.4%
Q2 25
15.5%
2.2%
Q1 25
10.2%
7.4%
Q4 24
13.6%
17.2%
Q3 24
13.5%
6.6%
Q2 24
14.3%
18.2%
EPS (diluted)
DXCM
DXCM
OTEX
OTEX
Q1 26
$0.67
Q4 25
$0.67
$0.66
Q3 25
$0.70
$0.58
Q2 25
$0.45
$0.11
Q1 25
$0.27
$0.35
Q4 24
$0.37
$0.87
Q3 24
$0.34
$0.32
Q2 24
$0.35
$0.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
OTEX
OTEX
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.3B
Total DebtLower is stronger
$6.4B
Stockholders' EquityBook value
$2.7B
$4.0B
Total Assets
$6.3B
$13.6B
Debt / EquityLower = less leverage
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
OTEX
OTEX
Q1 26
$917.7M
Q4 25
$917.7M
$1.3B
Q3 25
$1.8B
$1.1B
Q2 25
$1.2B
$1.2B
Q1 25
$904.9M
$1.3B
Q4 24
$606.1M
$1.1B
Q3 24
$621.2M
$1.0B
Q2 24
$939.2M
$1.3B
Total Debt
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
$6.4B
Q3 25
$6.4B
Q2 25
$6.4B
Q1 25
$6.4B
Q4 24
$6.4B
Q3 24
$6.4B
Q2 24
$6.4B
Stockholders' Equity
DXCM
DXCM
OTEX
OTEX
Q1 26
$2.7B
Q4 25
$2.7B
$4.0B
Q3 25
$2.7B
$4.0B
Q2 25
$2.6B
$3.9B
Q1 25
$2.3B
$4.1B
Q4 24
$2.1B
$4.2B
Q3 24
$2.0B
$4.1B
Q2 24
$2.4B
$4.2B
Total Assets
DXCM
DXCM
OTEX
OTEX
Q1 26
$6.3B
Q4 25
$6.3B
$13.6B
Q3 25
$7.5B
$13.5B
Q2 25
$7.3B
$13.8B
Q1 25
$6.8B
$13.8B
Q4 24
$6.5B
$13.7B
Q3 24
$6.4B
$13.8B
Q2 24
$6.8B
$14.2B
Debt / Equity
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
1.58×
Q3 25
1.61×
Q2 25
1.62×
Q1 25
1.55×
Q4 24
1.51×
Q3 24
1.55×
Q2 24
1.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
OTEX
OTEX
Operating Cash FlowLast quarter
$318.7M
Free Cash FlowOCF − Capex
$279.4M
FCF MarginFCF / Revenue
21.1%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
1.90×
TTM Free Cash FlowTrailing 4 quarters
$878.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
$294.0M
$318.7M
Q3 25
$659.9M
$147.8M
Q2 25
$303.0M
$158.2M
Q1 25
$183.8M
$402.2M
Q4 24
$301.4M
$348.0M
Q3 24
$199.5M
$-77.8M
Q2 24
$279.4M
$185.2M
Free Cash Flow
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
$192.1M
$279.4M
Q3 25
$579.4M
$101.2M
Q2 25
$208.9M
$124.0M
Q1 25
$96.8M
$373.8M
Q4 24
$176.8M
$306.7M
Q3 24
$88.3M
$-117.1M
Q2 24
$213.3M
$145.2M
FCF Margin
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
15.3%
21.1%
Q3 25
47.9%
7.9%
Q2 25
18.1%
9.5%
Q1 25
9.3%
29.8%
Q4 24
15.9%
23.0%
Q3 24
8.9%
-9.2%
Q2 24
21.2%
10.7%
Capex Intensity
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
8.1%
3.0%
Q3 25
6.7%
3.6%
Q2 25
8.1%
2.6%
Q1 25
8.4%
2.3%
Q4 24
11.2%
3.1%
Q3 24
11.2%
3.1%
Q2 24
6.6%
2.9%
Cash Conversion
DXCM
DXCM
OTEX
OTEX
Q1 26
Q4 25
1.10×
1.90×
Q3 25
2.33×
1.01×
Q2 25
1.69×
5.49×
Q1 25
1.74×
4.33×
Q4 24
1.99×
1.51×
Q3 24
1.48×
-0.92×
Q2 24
1.95×
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

OTEX
OTEX

Transferred At Point In Time$184.2M14%
Cybersecurity Enterprise Product$174.5M13%
Business Network Product$159.8M12%
Business Network Cloud Services And Subscriptions$151.4M11%
Content Cloud Services And Subscriptions$137.9M10%
Cybersecurity SMB Consumer Product$127.6M10%
Application Delivery Management Product$120.1M9%
IT Operations Management Product$113.3M9%
Professional Service And Other$82.5M6%
Analytics Product$58.1M4%
IT Operations Management Cloud Services And Subscriptions$7.8M1%

Related Comparisons